Oops! Something went wrong while submitting the form.
Ginkgo Bioworks is the leading horizontal platform for synthetic biology, running dozens of programs across industries from vaccine manufacturing and gene therapies to regenerative agriculture and bio-based cosmetics. In 2021, Ginkgo cemented its place as the leading synthetic biology company through its $15 billion SPAC, the largest biotech public debut in NYSE history.